These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2211357)

  • 1. Synthesis and oral activity of ME1207, a new orally active cephalosporin.
    Sakagami K; Atsumi K; Tamura A; Yoshida T; Nishihata K; Fukatsu S
    J Antibiot (Tokyo); 1990 Aug; 43(8):1047-50. PubMed ID: 2211357
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of new oral antimicrobial agents and the experience with cefprozil--a broad-spectrum oral cephalosporin.
    Klein JO
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S183. PubMed ID: 1617035
    [No Abstract]   [Full Text] [Related]  

  • 3. Orally active cephalosporins and penicillins.
    Böhme EH; Bambury RE; Baumann RJ; Erickson RC; Harrison BL; Hoffman PF; McCarty FJ; Schnettler RA; Vaal MJ; Wenstrup DL
    J Med Chem; 1980 Apr; 23(4):405-12. PubMed ID: 7381838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral cephalosporins for use in a parenteral-to-oral switch programme.
    Rimmer DM
    Infection; 1995; 23 Suppl 2():S87-90. PubMed ID: 8537139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on orally active cephalosporin esters.
    Fujimoto K; Ishihara S; Yanagisawa H; Ide J; Nakayama E; Nakao H; Sugawara S; Iwata M
    J Antibiot (Tokyo); 1987 Mar; 40(3):370-84. PubMed ID: 3570989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiology of oral cephalosporins.
    Cullmann W
    Antibiot Chemother (1971); 1995; 47():72-109. PubMed ID: 8554308
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oral cephalosporins in the treatment of suppurative-inflammatory diseases].
    Sidorenko SV
    Antibiot Khimioter; 1996; 41(11):33-42. PubMed ID: 9214285
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and oral activity of pivaloyloxymethyl 7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3(Z)- (4-methylthiazol-5-yl)vinyl-3-cephem-4-carboxylate (ME1207) and its related compound.
    Sakagami K; Atsumi K; Yamamoto Y; Tamura A; Yoshida T; Nishihata K; Fukatsu S
    Chem Pharm Bull (Tokyo); 1991 Sep; 39(9):2433-6. PubMed ID: 1804557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semisynthetic cephalosporins. III. Synthesis and structure activity relationships of novel orally active 7-[4-hydroxy-3-(substituted methyl)phenyl]-acetamido-3-cephem-4-carboxylic acids.
    Nudelman A; Patchornick A; Karoly-Hafely E; Braun F; Erickson RC
    J Antibiot (Tokyo); 1980 Jan; 33(1):76-82. PubMed ID: 7372553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally absorbable D-forphenicinol-cephalosporins.
    Koyama Y; Huang SP; Ikeda D; Hamada M; Kondo S; Takeuchi T
    J Antibiot (Tokyo); 1989 Jun; 42(6):993-9. PubMed ID: 2737957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CGP 9000: a new orally active, broad-spectrum cephalosporin.
    Zak O; Vischer WA; Schenk C; Tosch W; Zimmermann W; Regös J; Suter ER; Kradolfer F; Gelzer J
    J Antibiot (Tokyo); 1976 Jun; 29(6):653-5. PubMed ID: 950320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The penicillins and cephalosporins. Choosing among the newer agents.
    Wagner KF; Counts GW
    Postgrad Med; 1978 Sep; 64(3):109-16. PubMed ID: 100772
    [No Abstract]   [Full Text] [Related]  

  • 13. New orally active cephalosporin esters.
    Yamada H; Ueda S; Mutoh M; Nagata H; Nouda H; Fukasawa M; Okuda T
    J Antibiot (Tokyo); 1990 May; 43(5):578-83. PubMed ID: 2358409
    [No Abstract]   [Full Text] [Related]  

  • 14. FR192752, a novel orally active cephalosporin synthesis and biological properties.
    Yamamoto H; Kawabata K; Tawara S; Takasugi H; Tanaka H
    J Antibiot (Tokyo); 2000 Oct; 53(10):1223-7. PubMed ID: 11132972
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field. Pediatric Study Group of ME1207].
    Fujii R; Yoshioka H; Okuno A; Fujita K; Murono K; Maruyama S; Sakata H; Iseki K; Wagatsuma Y; Fukushima N
    Jpn J Antibiot; 1993 Jan; 46(1):95-114. PubMed ID: 8455336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo activity of DQ-2556, a new cephalosporin.
    Ishida Y; Miyazaki S; Yamaguchi K; Goto S
    Chemotherapy; 1995; 41(1):5-13. PubMed ID: 7875022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo antibacterial activity of FK041, a new orally active cephalosporin.
    Tawara S; Hatano K; Wakai Y; Matsumoto S; Watanabe Y; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1999 Jul; 52(7):660-5. PubMed ID: 10513846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of E1101, a novel oral cephalosporin, against bacteria causing infections in obstetric and gynecological patients.
    Mikamo H; Sato Y; Hayasaki Y; Kawazoe K; Tamaya T
    Chemotherapy; 1998; 44(5):328-30. PubMed ID: 9732148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of (cyclopentenopyridinium) thiomethylcephalosporins.
    Katano K; Ogino H; Iwamatsu K; Nakabayashi S; Yoshida T; Komiya I; Tsuruoka T; Inouye S; Kondo S
    J Antibiot (Tokyo); 1990 Sep; 43(9):1150-9. PubMed ID: 2211377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semisynthetic cephalosporins. Synthesis and structure-activity relationships of 7-(1-pyrryl)- and 7-(1-indolyl)acetamidocephalosporin derivatives.
    Nudelman A; Karoly H; Braun F; Böhme EH; Erickson RC
    J Med Chem; 1978 Sep; 21(9):962-4. PubMed ID: 722761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.